The study, nicknamed COMFORT—Clinical Study Of A Micro-Implantable Pulse Generator FOR the Treatment of Peripheral ...

A key highlight of the quarter came right at the end when Nevro won FDA approval for HFX AdaptiveAI, an AI-powered, ...

IPG Photonics IPGP is set to give its latest quarterly earnings report on Tuesday, 2024-10-29. Here's what investors need to know before the announcement. Analysts estimate that IPG Photonics will ...

Are you a print subscriber? Activate your account. 37 min 58 sec ago By Tim Nudd - 1 hour 18 min ago By Brandon Doerrer - 2 hours 10 min ago By Ad Age Staff - 2 hours 51 min ago By Asa Hiken - 2 ...

IPG's revenue before billable expenses shows a slight decline in Q3 2024, indicating competitive challenges. Impairment of goodwill suggests strategic realignments and potential market ...

Occipital nerve stimulation is widely considered to be the first choice neurostimulation procedure for chronic cluster headache. Hypothalamic stimulation is an invasive procedure for drug ...

Thousand Oaks, CA-based biotechnology company Amgen has selected IPG Mediabrands to handle its U.S. media agency assignments after a formal review that began earlier this year. Incumbents included ...

Unlimited access to Campaign Asia-Pacific content* including its archive of 70,000+ articles. No monthly limits! Premium member-only articles & analysis Campaign’s annual APAC Agency Report Cards ...

IPG reported flat organic revenue growth in the September quarter and forecasts the full year at just 1% as the company works to fix underperformance in some parts of the business. The global ...

Image credit: Lightspring / Shutterstock. Nexalin Technology has partnered with the University of California, San Diego, to start a clinical trial evaluating the company’s neurostimulation device, Gen ...